Identification

Listing sponsor / Agent

Bryan, Garnier & Co

Symbol
ALINT
ISIN code
FR0010908723
Exchange / Market
Euronext Growth
Trading location
Paris
ICB
Biotechnology
Activity description

IntegraGen’s vocation is firstly to establish the link between innovations derived from molecular research and medical practise, by developing biomarkers for autism and oncology specifically intended for clinical use, and subsequently to make its genomics services available to practitioners and researchers thanks to its exceptional technological and scientific know-how.
IntegraGen has become one of the reference partners for teams working in molecular genetics research. At the heart of a network of geneticists, clinical practitioners and biostatisticians and with perfect command of the most advanced technologies in genomics, bioinformatics and biostatistics, IntegraGen is a major actor in clinical genomics at the service of patients, clinical practitioners and researchers.

Website address
http://www.integragen.fr
Issuer website
http://www.integragen.fr

Operation

IPO date
Fri 18/06/2010
IPO type
Initial Public offering
Catégorie
IPO